Erchonia’s Lunula Laser Gains Traction in Korean Market

Posted by & filed under Press Releases.

“It’s very helpful for patients to have a non-thermal, painless treatment, covered by insurance. Doctors also save time with an effective and comfortable procedure for patients. The mutual needs of both doctors and patients are met with Lunula.”   Melbourne, Fla., May 21, 2019 — Erchonia Corporation, the global leader in low-level laser technology (“3LT”),… Read more »

Erchonia to Exhibit at 2019 Arab Health Conference in Dubai

Posted by & filed under Press Releases.

“We are very excited by the growth that we are achieving across the world and are very much looking forward to Arab Health.”   Melbourne, Fla., January 10, 2019 — Erchonia Corporation, the global leader in low level laser therapy technology (“3LT”), today announces the company will be exhibiting at the upcoming 2019 Arab Health… Read more »

Erchonia & InnerScope Hearing Technologies to Conduct FDA Clinical Trial to Treat Tinnitus with Low Level Laser Technology

Posted by & filed under Press Releases.

Erchonia Corporation today announces a joint development agreement with InnerScope Hearing Technologies to conduct clinical research and trials for the purpose of obtaining 510(k) clearances from the FDA for 3LT devices to treat hearing-related conditions, including tinnitus. “We’re hopeful our partnership with InnerScope can make a real difference in patients’ lives and eventually provide a… Read more »

CBS’s “The Doctors” Showcases the Remarkable Lunula Laser as a Solution for Nail Fungus

Posted by & filed under Press Releases.

Top-Rated Daytime Talk Show Features a Confident and Dramatic Patient Result “We know our Lunula Laser can help so many people achieve healthy, clear nail growth without experiencing any harmful side-effects” Melbourne, FL (PRWEB)October 22, 2018 Erchonia, the leading low-level laser technology manufacturer in the world today announces the company’s Lunula Laser was featured on… Read more »

Erchonia Submits Data to US FDA to Support Low-Level Laser 510(k) Market Clearance for Autism

Posted by & filed under Press Releases.

Quadruple-Blind laser study proves success in treating Autism in children and adolescents. “The results are so strong, nobody can argue them.” MELBOURNE, Fla. (PRWEB)September 05, 2018 Erchonia, the World Leader in Low Level Laser technology, announces today that they have submitted data to the US FDA to support a 510(k) market clearance for Autism. The… Read more »

Erchonia Donates One Hundred and Fifty Thousand Dollars’ worth of Low-Level Lasers to the New York College of Podiatric Medicine & Foot Center of New York

Posted by & filed under Press Releases.

Pain-Free, Non-Surgical Laser Treatment Options   MELBOURNE, Fla. (PRWEB) July 25, 2018 We are pleased to announce New York College of Podiatric Medicine (NYCPM) & Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including both Lunula Lasers and FX 635 Lasers.  NYCPM provides unrivaled excellence in podiatric medical education and clinical… Read more »

FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

Posted by & filed under Press Releases.

First and Only FDA Market Cleared Low-Level Laser Treatment Option Melbourne, FL (PRWEB) July 17, 2018 Erchonia Corporation announces another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category… Read more »

Lunula Laser targets nail fungus WKRC June 2018

Posted by & filed under In the News.

Lunula Laser targets nail fungus   by LIZ BONIS, WKRC Tuesday, June 19th 2018 Click Here for the Full Story There’s something new to keep your toes healthy this summer sandal season. It’s a new laser to help your toenails look a whole lot better. This “flip flop season”, Melinda Wigginton has a new “weapon”… Read more »